EUVIMEDEUVIMED entdecken
Crossref

Multimodal phototherapy agents target lipid droplets for near-infrared imaging-guided type I photodynamic/photothermal therapy

Xianjiao Tang, Liping Chen, Yuhan Wang, Pengwei Chen, Lin-Song Li, Xiaojing Yang, Mei-Xia Zhao

Acta Biomaterialia · 2024-05 · 180 · 394-406

DOI: 10.1016/j.actbio.2024.04.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-05. Verfasst von Xianjiao Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: Photochemotherapy, Photothermal Therapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The construction and optimization of a single phototherapeutic agent with photoluminescence, type I photodynamic therapy (PDT), and photothermal therapy (PTT) functions remain challenging. In this study, we aimed to design and synthesize four donor-acceptor (D-A) type aggregation-induced emission molecules: PSI, TPSI, PSSI, and TPSSI. We employed phenothiazine as an electron donor and 1,3-bis(dicyanomethylidene)indan as a strong electron acceptor in the synthesis process. Among them, TPSSI exhibited efficient type I reactive oxygen species generation, high photothermal conversion efficiency (45.44 %), and near-infrared emission. These observations can be attributed to the introduction of a triphenylamine electron donor group and a thiophene unit, which resulted in increased D-A strengths, a reduced singlet-triplet energy gap, and increased free intramolecular motion. TPSSI was loaded into bovine serum albumin to prepare biocompatible TPSSI nanoparticles (NPs). Our results have indicated that TPSSI NPs can target lipid droplets with negligible dark toxicity and can efficiently generate O2•- in hypoxic tumor environments. Moreover, TPSSI NPs selectively targeted 4T1 tumor tissues and exhibited a good PDT-PTT synergistic effect in vitro and in vivo. We believe that the successful preparation of multifunctional phototherapeutic agents will promote the development of efficient tumor diagnosis and treatment technologies. STATEMENT OF SIGNIFICANCE: The construction of a single phototherapeutic agent with photoluminescence, type I photodynamic therapy, and photothermal therapy functions, and its optimization remain challenging. In this study, we construct four donor-acceptor aggregation-induced emission molecules using phenothiazine as an electron donor and 1,3-Bis(dicyanomethylidene)indan as a strong electron acceptor. By optimizing the molecular structure, an integrated phototherapy agent with fluorescence imaging ability and high photodynamic / photothermal therapy performance was prepared. We believe that the successful preparation of multifunctional phototherapeutic agents will promote the development of efficient tumor diagnosis and treatment technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyPhotothermal TherapyAnimalsMiceFemaleMice, Inbred BALB CCell Line, TumorInfrared RaysNanoparticles

Stichwörter der Autor:innen

CancerNear-infrared emissionPhotothermal therapyType I photodynamic therapytarget lipid droplets

Autor:innen und Institutionen

  • Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng 475004, China.
  • Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng 475004, China. Electronic address: 10350027@vip.henu.edu.cn.
  • Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng 475004, China. Electronic address: zhaomeixia2011@henu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tang, X., Chen, L., Wang, Y., Chen, P., Li, L. S., Yang, X., & Zhao, M. X. (2024). Multimodal phototherapy agents target lipid droplets for near-infrared imaging-guided type I photodynamic/photothermal therapy. Acta Biomaterialia, 180, 394-406. https://doi.org/10.1016/j.actbio.2024.04.014

Vancouver

Tang X, Chen L, Wang Y, Chen P, Li LS, Yang X, et al. Multimodal phototherapy agents target lipid droplets for near-infrared imaging-guided type I photodynamic/photothermal therapy. Acta Biomaterialia. 2024;180:394-406. doi:10.1016/j.actbio.2024.04.014

BibTeX
@article{Tang2024,
  author = {Tang, Xianjiao and Chen, Liping and Wang, Yuhan and Chen, Pengwei and Li, Lin-Song and Yang, Xiaojing and Zhao, Mei-Xia},
  title = {Multimodal phototherapy agents target lipid droplets for near-infrared imaging-guided type I photodynamic/photothermal therapy},
  journal = {Acta Biomaterialia},
  year = {2024},
  volume = {180},
  pages = {394--406},
  doi = {10.1016/j.actbio.2024.04.014}
}
Kostenlos starten →